Attached files
file | filename |
---|---|
EX-10.7 - EX-10.7 - CytoDyn Inc. | d855842dex107.htm |
EX-10.6 - EX-10.6 - CytoDyn Inc. | d855842dex106.htm |
EX-31.2 - EX-31.2 - CytoDyn Inc. | d855842dex312.htm |
EX-32.1 - EX-32.1 - CytoDyn Inc. | d855842dex321.htm |
EX-31.1 - EX-31.1 - CytoDyn Inc. | d855842dex311.htm |
EX-10.9 - EX-10.9 - CytoDyn Inc. | d855842dex109.htm |
EX-10.8 - EX-10.8 - CytoDyn Inc. | d855842dex108.htm |
EX-10.5 - EX-10.5 - CytoDyn Inc. | d855842dex105.htm |
10-Q - 10-Q - CytoDyn Inc. | d855842d10q.htm |
Exhibit 32.2
Certification of Chief Financial Officer
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the Quarterly Report of CytoDyn Inc. (the Company) on Form 10-Q for the fiscal quarter ended November 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), I, Craig S. Eastwood, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:
(1) | The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
(2) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January 9, 2020 | /s/ Craig S. Eastwood | |||
Craig S. Eastwood | ||||
Chief Financial Officer |
42